| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5571527 | Seminars in Oncology Nursing | 2017 | 12 Pages |
Abstract
Treatment of multiple myeloma is largely dependent on risk factors in which specific genetic alterations play a large role. Clinicians should be aware of these genetic changes and how they may influence the individual treatment plan for each patient.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kevin Brigle, Barbara Rogers,